Papers
1
Total Citations
11
H-Index
1
About
Zhao Wu is a pioneering researcher at the intersection of nanobiotechnology and cancer therapy, with a primary focus on biohybrid systems, ferroptosis-based treatments, and advanced imaging techniques. Their most notable contribution is the development of self-mineralized biohybrids for synergistic tumor therapy, as demonstrated in their highly cited 2025 paper "Direct Visualization of Self-Mineralized Biohybrid-Triggered Apoptosis–Ferroptosis Synergistic Tumor Therapy by Cryo-Soft X-ray Tomography." This work introduces SO@FeS, a system leveraging the facultative anaerobic bacterium *Shewanella* to construct a self-mineralized platform that triggers both apoptosis and ferroptosis in cancer cells. By employing cutting-edge Cryo-Soft X-ray Tomography, Wu achieved direct visualization of these therapeutic mechanisms, offering unprecedented insights into nanomaterial-cell interactions. With 11 citations already, this paper underscores Wu's impact in merging living organisms with nanoparticles for tumor-selective therapy. Their research holds promise for advancing precision oncology, and Wu continues to be recognized for innovative approaches that bridge materials science, microbiology, and biomedical engineering.
Research Focus
Key Achievements
Top Papers
- 1